![FDA approves Eversense E3 6-month continuous glucose monitor that requires fewer fingerstick blood glucose measurements - NotebookCheck.net News FDA approves Eversense E3 6-month continuous glucose monitor that requires fewer fingerstick blood glucose measurements - NotebookCheck.net News](https://www.notebookcheck.net/fileadmin/Notebooks/News/_nc3/Eversense_CGM_system_90_day_now_180_days_blood_glucose_drdNBC.jpg)
FDA approves Eversense E3 6-month continuous glucose monitor that requires fewer fingerstick blood glucose measurements - NotebookCheck.net News
Beyond Type 1 - NOW APPROVED BY THE FDA - a new CGM is on the scene! The Eversense from Senseonics is the first implantable continuous glucose monitor. It lasts 90 days
![DiabetesMine on X: "Curious how competing Continuous Glucose Monitoring tech stacks up? See this graph & our story on new implantable #CGM https://t.co/q0lVmtsHyq / #diabetes #T1D #artificialpancreas #mhealth #DOC #WeAreNotWaiting -AT https://t.co ... DiabetesMine on X: "Curious how competing Continuous Glucose Monitoring tech stacks up? See this graph & our story on new implantable #CGM https://t.co/q0lVmtsHyq / #diabetes #T1D #artificialpancreas #mhealth #DOC #WeAreNotWaiting -AT https://t.co ...](https://pbs.twimg.com/media/DT2AJVTXkAI669p.png)